Inozyme PharmaINZY
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
盤後
0
0
(0%)
01/01 08:00 (UTC+8)
Inozyme PharmaINZY
0
0
(0%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 27,688 | 27,171 | 24,850 | 27,664 | 24,345 | 22,808 | 18,074 | 16,394 | 18,369 | 19,533 |
研發費用 | 20,379 | 22,473 | 19,890 | 21,757 | 19,111 | 17,983 | 13,341 | 11,666 | 11,857 | 13,837 |
推銷及管理費用 | 5,409 | 4,698 | 4,960 | 5,907 | 5,234 | 4,825 | 4,733 | 4,728 | 6,512 | 5,696 |
非經常性項目費用 | 1,900 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -27,688 | -27,171 | -24,850 | -27,664 | -24,345 | -22,808 | -18,074 | -16,394 | -18,369 | -19,533 |
其他收入及費用 | 1,055 | 1,519 | 1,696 | 2,026 | 2,323 | 2,545 | 337 | 483 | 965 | 989 |
利息費用 | 1,406 | 1,422 | 1,416 | 1,395 | 1,325 | 1,281 | -1,099 | -328 | - | - |
稅前純益 | -28,039 | -27,074 | -24,570 | -27,033 | -23,347 | -21,544 | -16,638 | -15,583 | -17,404 | -18,544 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -28,039 | -27,074 | -24,570 | -27,033 | -23,347 | -21,544 | -16,638 | -15,583 | -17,404 | -18,544 |
基本每股稅後盈餘(元) | -0.44 | -0.41 | -0.39 | -0.44 | -0.38 | - | -0.29 | -0.35 | -0.40 | -0.42 |
稀釋每股稅後盈餘(元) | -0.44 | -0.42 | -0.39 | -0.43 | -0.38 | -0.35 | -0.28 | -0.34 | -0.40 | -0.42 |
基本平均股數(千股) | 64278.00 | 64256.00 | 63276.00 | 61943.00 | 61772.00 | - | 56758.00 | 44860.00 | 43720.00 | 43785.00 |
稀釋平均股數(千股) | 64278.00 | 64256.00 | 63276.00 | 61943.00 | 61772.00 | - | 56758.00 | 44860.00 | 43720.00 | 43785.00 |
還原基本每股稅後盈餘(元) | -0.44 | -0.41 | -0.39 | -0.44 | -0.38 | - | -0.29 | -0.35 | -0.40 | -0.42 |
還原稀釋每股稅後盈餘(元) | -0.44 | -0.42 | -0.39 | -0.43 | -0.38 | -0.35 | -0.28 | -0.34 | -0.40 | -0.42 |
還原基本平均股數(千股) | 64,278 | 64,256 | 63,276 | 61,943 | 61,772 | - | 56,758 | 44,860 | 43,720 | 43,785 |
還原稀釋平均股數(千股) | 64,278 | 64,256 | 63,276 | 61,943 | 61,772 | - | 56,758 | 44,860 | 43,720 | 43,785 |
EBITDA(千元) | -27,142 | -26,017 | -23,772 | -27,018 | -23,956 | -22,158 | -19,013 | -16,806 | -17,943 | -18,935 |